Stay updated with breaking news from Glaxo Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On April 30, the Federal Trade Commission (FTC) announced that it was expanding its campaign against allegedly improper patent listings in the U.S. Food & Drug Administration’s (FDA) Orange Book.
Investegate announcements from Holding(s) in Company
Citations 2023 LiveLaw (Del) 917 to 2023 LiveLaw (Del) 1039NOMINAL INDEXPCIT Versus Pepsico India Holding Pvt. Ltd. 2023 LiveLaw (Del) 917 ADITYA N PRASAD v. GOVERNMENT OF NCT OF DELHI & ORS. 2023...
The Delhi High Court has observed that the level of tolerance allowable for confusion among consumers is “very low” in pharmaceutical products which cannot be easily condoned.Justice Prathiba M Singh...
(2023-08-15) Searchlight Pharma Announces Suvexx® Launch in Europe, along with Deal Expansion to all E.U. Markets